Disposition of roxithromycin in the epididymis after repeated oral administration.
Disposition of roxithromycin in the epididymis after repeated oral administration.
复制标题
重复口服后罗红霉素在附睾中的分布。
DOI:
10.1093/jac/30.2.197
复制
发表时间:
1992
期刊:
影响因子:
--
通讯作者:
Françoise Bressolle
中科院分区:
文献类型:
--
作者:
Pierre Costa;Francois Desclaux d'Arramon;Anne Gouby;Henri Navratil;F. Gény;M. Galtier;Françoise Bressolle
The epididymal penetration of roxithromycin was studied in order to evaluate the drug for use in the treatment of epididymo-orchitis. Seventeen patients hospitalized for surgery as part of treatment for prostatic adenoma or prostatic cancer were premedicated orally with roxithromycin 150 mg bd for three days followed by 150 mg pre-operatively (3 h before surgical incision). Roxithromycin concentrations in serum and epididymis were determined by microbiological assay. The mean epididymal concentrations were 6.48 +/- 4.88 and 5.98 +/- 3.92 mg/kg for left and right epididymis respectively and the corresponding mean tissue/serum ratios 0.88 +/- 0.57 and 0.84 +/- 0.53. The wide intersubject variation in the concentration of roxithromycin found in serum and tissue is commonly seen with other macrolide antibiotics. The concentrations observed in this study in serum and tissue were greater than the MIC90s for Chlamydia trachomatis (0.25 to 1 mg/L), and Ureaplasma urealyticum (0.5 mg/L).